Global Ganja Report

In a paradox, New York authorities are finally unleashing the long-anticipated crackdown on the state’s legion and proliferating unlicensed cannabis retailers—while the licensing program continues to be slowed by obstacles, including legal challenges.

With the failure of Democratic Gov. John Carney to either sign or veto two bills on his desk, Delaware became the latest state to legalize cannabis on April 22. Carney allowed House Bill 1 and House Bill 2 to become law without his signature.

Rights for medicinal cannabis users in the workplace have not kept pace with the law in states that have embraced medical and even “recreational” use. Now a case in Vermont may push state and federal authorities alike to close the loopholes that allow workers to be dismissed—and denied unemployment insurance—for using state-legal medicine.

Raphael Mechoulam, the ground-breaking cannabis researcher who first isolated and identified THC in 1964, died in Israel at the age of 92. His passing was announced March 10 by Jerusalem's Hebrew University, where Mechoulam co-founded the Multidisciplinary Center for Cannabinoid Research in 2017.

Small producers have long been wary of the cannabis industry coming under domination by multi-state operators with the worst practices of corporate America. But the revelations of Russian oligarch money in the coffers of leading MSO Curaleaf appear to vindicate even the most cynical observers. These follow a slew of controversies concerning product safety and labor rights at the company.

The arrival of a major US multi-state operator in Bangkok is a sign of the global cannabis industry's big ambitions for Thailand, the first Asian country to decriminalize. But with enabling legislation still pending, the regulatory environment remains uncertain.

David Crosby, a giant of California's 1960s folk-rock scene and leading light of the Woodstock generation, died Jan. 19 at the age of 81. To the end, he was an unapologetic advocate of cannabis legalization, serving as a member of the advisory board of the National Organization for the Reform of Marijuana Laws (NORML).

It’s a fairly open secret that Brittney Griner was Putin’s geopolitical pawn when she was in Russian detention for nine months on a minor cannabis charge. And her freedom came at a high price—swapped for a Russian “Death Merchant” who now boasts he’ll aid Putin’s savage war in Ukraine. But GOP exploitation of Griner indicates that she remains a political pawn even as a free woman in America.